Apellis Pharmaceuticals Inc Előre P/E
Mi az Apellis Pharmaceuticals Inc Előre P/E?
A Előre P/E az Apellis Pharmaceuticals Inc - -11.54
Mi a Előre P/E meghatározása?
Az előrejelzett ár / jövedelem arány a vállalat tőzsdei árának és a társaság becsült részvényenkénti eredményének aránya a következő tizenkét hónapban.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Előre P/E a Health Care szektor a NASDAQ-on cégekben a Apellis Pharmaceuticals Inc -hoz képest
Mit csinál Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
előre p/e -hoz hasonló cégek Apellis Pharmaceuticals Inc
- Biostage nak Előre P/E -12.00 van
- Immunovant Inc nak Előre P/E -11.92 van
- U.S. Xpress Enterprises Inc nak Előre P/E -11.88 van
- CollPlant Biotechnologies Ltd nak Előre P/E -11.63 van
- Oncocyte nak Előre P/E -11.63 van
- Parrot SA nak Előre P/E -11.57 van
- Apellis Pharmaceuticals Inc nak Előre P/E -11.54 van
- Biostage nak Előre P/E -11.43 van
- Soligenix Inc nak Előre P/E -11.34 van
- Abivax SA nak Előre P/E -11.32 van
- GrowGeneration Corp nak Előre P/E -11.31 van
- Obalon Therapeutics Inc nak Előre P/E -11.30 van
- Cassava Sciences Inc nak Előre P/E -11.29 van